These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24511222)

  • 1. One-year results of intravitreal ranibizumab combined with reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.
    Sakurai M; Baba T; Kitahashi M; Yokouchi H; Kubota-Taniai M; Bikbova G; Oshitari T; Yamamoto S
    Clin Ophthalmol; 2014; 8():235-41. PubMed ID: 24511222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen.
    Lai K; Li Y; Zhou L; Zhong X; Huang C; Xu F; Lu L; Ge J; Jin C
    BMC Ophthalmol; 2018 Jun; 18(1):144. PubMed ID: 29925341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of one-year results of photodynamic therapy combined with ranibizumab or aflibercept for treating polypoidal choroidal vasculopathy.
    Ito A; Maruyama-Inoue M; Kitajima Y; Sato S; Inoue T; Yamane S; Kadonosono K
    PLoS One; 2020; 15(6):e0235213. PubMed ID: 32579608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-year results of reduced-fluence photodynamic therapy combined with intravitreal ranibizumab for typical age-related macular degeneration and polypoidal choroidal vasculopathy.
    Yoshida Y; Kohno T; Yamamoto M; Yoneda T; Iwami H; Shiraki K
    Jpn J Ophthalmol; 2013 May; 57(3):283-93. PubMed ID: 23413039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-year visual outcomes of intravitreal ranibizumab with or without photodynamic therapy for polypoidal choroidal vasculopathy.
    Sakai T; Okano K; Kohno H; Tsuneoka H
    Acta Ophthalmol; 2016 Dec; 94(8):e765-e771. PubMed ID: 27237048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INITIAL VERSUS DELAYED PHOTODYNAMIC THERAPY IN COMBINATION WITH RANIBIZUMAB FOR TREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY: The Fujisan Study.
    Gomi F; Oshima Y; Mori R; Kano M; Saito M; Yamashita A; Iwata E; Maruko R;
    Retina; 2015 Aug; 35(8):1569-76. PubMed ID: 25830698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 3-year outcomes of photodynamic therapy combined with intravitreal ranibizumab or aflibercept for polypoidal choroidal vasculopathy in a European cohort.
    Liu S; Chhabra R
    Graefes Arch Clin Exp Ophthalmol; 2022 Nov; 260(11):3533-3542. PubMed ID: 35678837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year follow-up of ranibizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy.
    Nemoto R; Miura M; Iwasaki T; Goto H
    Clin Ophthalmol; 2012; 6():1633-8. PubMed ID: 23109800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-year results of photodynamic therapy with or without intravitreal ranibizumab for polypoidal choroidal vasculopathy.
    Sakurada Y; Iijima H
    J Ocul Pharmacol Ther; 2013 Nov; 29(9):832-6. PubMed ID: 23962035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of polypoidal choroidal vasculopathy with photodynamic therapy combined with intravitreal injections of ranibizumab.
    Tomita K; Tsujikawa A; Yamashiro K; Ooto S; Tamura H; Otani A; Nakayama Y; Yoshimura N
    Am J Ophthalmol; 2012 Jan; 153(1):68-80.e1. PubMed ID: 21907965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predicting 2-year treatment results of ranibizumab therapy for polypoidal choroidal vasculopathy in eyes with good baseline visual acuity.
    Mori R; Tanaka K; Yuzawa M
    Medicine (Baltimore); 2018 Jun; 97(25):e11188. PubMed ID: 29924037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of intravitreal ranibizumab in exudative age-related macular degeneration (AMD): comparison between typical neovascular AMD and polypoidal choroidal vasculopathy over a 1 year follow-up.
    Matsumiya W; Honda S; Kusuhara S; Tsukahara Y; Negi A
    BMC Ophthalmol; 2013 Apr; 13():10. PubMed ID: 23557322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between pachychoroid and long-term treatment outcomes of photodynamic therapy with intravitreal ranibizumab for polypoidal choroidal vasculopathy.
    Azuma K; Okubo A; Nomura Y; Zhou H; Terao R; Hashimoto Y; Asano KS; Azuma K; Inoue T; Obata R
    Sci Rep; 2020 May; 10(1):8337. PubMed ID: 32433551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined reduced fluence photodynamic therapy and intravitreal ranibizumab for polypoidal choroidal vasculopathy.
    Ricci F; Calabrese A; Regine F; Missiroli F; Ciardella AP
    Retina; 2012 Jul; 32(7):1280-8. PubMed ID: 22218148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy.
    Wong IY; Shi X; Gangwani R; Zhao P; Iu LP; Li Q; Ng A; Li X
    BMC Ophthalmol; 2015 Jun; 15():66. PubMed ID: 26122636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal ranibizumab injection combined with photodynamic therapy for polypoidal choroidal vasculopathy.
    Li J; Sun J; Li B; Liu Z
    Exp Ther Med; 2018 Feb; 15(2):1546-1551. PubMed ID: 29434739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-year results of photodynamic therapy combined with intravitreal anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy.
    Kim M; Kim K; Kim DG; Yu SY; Kwak HW
    Ophthalmologica; 2011; 226(4):205-13. PubMed ID: 21893965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment results at 1 year of ranibizumab therapy for polypoidal choroidal vasculopathy in eyes with good visual acuity.
    Mori R; Yuzawa M; Akaza E; Haruyama M
    Jpn J Ophthalmol; 2013 Jul; 57(4):365-71. PubMed ID: 23665979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practicability confirmation by meta-analysis of intravitreal ranibizumab compared to photodynamic therapy to treat polypoidal choroidal vasculopathy.
    Liu L; Ma J; Duan P; Liu Y; Yin ZQ
    Mol Vis; 2015; 21():1130-41. PubMed ID: 26539025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-year results of combined intravitreal ranibizumab and photodynamic therapy for polypoidal choroidal vasculopathy.
    Saito M; Iida T; Kano M; Itagaki K
    Graefes Arch Clin Exp Ophthalmol; 2013 Sep; 251(9):2099-110. PubMed ID: 23553286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.